This $339,038 federal Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) aims to study the prevalence and impact of frailty in older adults with polymyalgia rheumatica (PMR), a common rheumatic condition. The grant will utilize Medicare data to create a cohort of older adults with PMR and examine:
-
The association between frailty and the duration of glucocorticoid treatment and prescription analgesic use in this population.
-
The relationship between the utilization of physical therapy (PT) services and glucocorticoid treatment duration, including the impact on frail versus non-frail older adults with PMR.
The project will run from Sep 2024 to Aug 2026 and includes a sub-award to Weill Medical College of Cornell University to support the research. This work seeks to provide a better understanding of the role of frailty in PMR management and the potential benefits of function-modifying interventions like PT for improving outcomes in this vulnerable patient population.
Generated 3/25/25, 4:55 AM